West Pharmaceutical Services Inc. (WST) Sets New 52-Week High at $84.05
West Pharmaceutical Services Inc. (NYSE:WST) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $84.05 and last traded at $84.03, with a volume of 329,900 shares changing hands. The stock had previously closed at $81.73.
A number of equities research analysts recently issued reports on WST shares. Janney Montgomery Scott restated a “buy” rating and issued a $90.00 price objective (up from $69.00) on shares of West Pharmaceutical Services in a research note on Friday, May 13th. Jefferies Group boosted their price objective on West Pharmaceutical Services from $67.00 to $77.00 and gave the company a “hold” rating in a research note on Friday, July 29th. Finally, Zacks Investment Research upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $91.00 price objective on the stock in a research note on Friday, August 5th.
The company has a market cap of $6.15 billion and a PE ratio of 61.20. The firm’s 50 day moving average is $80.46 and its 200 day moving average is $72.93.
West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, July 28th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.03. The company had revenue of $388 million for the quarter, compared to the consensus estimate of $384.58 million. During the same quarter in the previous year, the business earned $0.47 earnings per share. West Pharmaceutical Services’s revenue was up 7.9% compared to the same quarter last year. On average, equities analysts predict that West Pharmaceutical Services Inc. will post $2.23 EPS for the current year.
In other news, Director Paula A. Johnson sold 3,042 shares of the firm’s stock in a transaction on Tuesday, August 23rd. The stock was sold at an average price of $81.55, for a total transaction of $248,075.10. Following the completion of the transaction, the director now directly owns 38,450 shares in the company, valued at $3,135,597.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
West Pharmaceutical Services, Inc is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company’s products include stoppers and seals for vials, prefillable syringe components and systems, components for intravenous and blood collection systems, safety and administration systems, advanced injection systems, and contract design and manufacturing services.